The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
The closing price of Aldeyra Therapeutics Inc (NASDAQ: ALDX) was $2.70 for the day, down -3.91% from the previous closing price of $2.81. In other words, the price has decreased by -$3.91 from its previous closing price. On the day, 1.11 million shares were traded.
Ratios:
Our analysis of ALDX’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 5.48 and its Current Ratio is at 5.48. In the meantime, Its Debt-to-Equity ratio is 0.22 whereas as Long-Term Debt/Eq ratio is at 0.21.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Apr 03 ’25 when PERCEPTIVE ADVISORS LLC sold 3,400,000 shares for $1.42 per share. The transaction valued at 4,828,000 led to the insider holds 5,875,851 shares of the business.
Machatha Stephen sold 16,041 shares of ALDX for $75,975 on Aug 12 ’24. The Chief Development Officer now owns 236,771 shares after completing the transaction at $4.74 per share. On Aug 12 ’24, another insider, Greenberg Bruce, who serves as the insider of the company, sold 10,834 shares for $4.74 each. As a result, the insider received 51,313 and left with 126,382 shares of the company.
Stock Price History:
Over the past 52 weeks, ALDX has reached a high of $7.20, while it has fallen to a 52-week low of $1.14. The 50-Day Moving Average of the stock is -40.86%, while the 200-Day Moving Average is calculated to be -46.30%.
Shares Statistics:
A total of 59.65M shares are outstanding, with a floating share count of 58.16M. Insiders hold about 2.90% of the company’s shares, while institutions hold 54.68% stake in the company.
